Understanding the economic burden of heart failure in China: impact on disease management and resource utilization-Reference-Cited by-同舟云学术

Understanding the economic burden of heart failure in China: impact on disease management and resource utilization

Published:2017-03-12 Issue:5 Volume:20 Page:549-553
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Huang Jun¹,Yin Hongjun²,Zhang Milun³,Ni Qian³,Xuan Jianwei⁴

Affiliation:

1. The First Affiliated Hospital of Nanjing Medical University, Nanjing, PR China;

2. Centennial Scientific Co. Ltd., Warren, NJ, USA;

3. Novartis Pharmaceuticals (China), Beijing, PR China;

4. Health Economics Research Institute, Sun Yat-sen University, Guagzhou, PR China

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2017.1297309

Reference18 articles.

1. The epidemiological features of heart failure in developing countries: a review of the literature

2. The US Centers for Disease Control and Prevention. CDC in China: factsheet. Centers for Disease Control and Prevention. Atlanta, USA. http://www.cdc.gov/globalhealth/countries/china/pdf/china.pdf. Accessed July 21, 2016

3. Association between process indicators and in-hospital mortality among patients with chronic heart failure in China

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Health Care Utilization in Different Usual Sources of Care Among Older People With Cardiovascular Disease in China: Evidence From the Study on Global Ageing and Adult Health;International Journal of Public Health;2024-01-03

2. Cost-Effectiveness of New Quadruple Therapy Compared With Standard Treatment for Patients With Heart Failure in China;Journal of Cardiovascular Pharmacology;2024-01

3. Cost-Effectiveness of Dapagliflozin in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: the DELIVER Trial;Cardiovascular Drugs and Therapy;2023-12-14

4. Potentially inappropriate medications among older patients with Parkinson’s disease: a cross-sectional analysis of a national health insurance database in China;BMC Geriatrics;2023-12-08

5. Heart failure: a prevalence-based and model-based cost analysis;Frontiers in Cardiovascular Medicine;2023-12-01